地榆升白片预防化疗引起骨髓抑制临床观察.doc

地榆升白片预防化疗引起骨髓抑制临床观察.doc

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
地榆升白片预防化疗引起骨髓抑制临床观察

地榆升白片预防化疗引起骨髓抑制临床观察[摘要] 目的:观察地榆升白片对恶性肿瘤患者化疗引起的骨髓抑制的预防效果。方法:全组88例恶性肿瘤患者随机分为治疗组46例和对照组42例。治疗组在化疗同时服用地榆升白片,每次4片,每日3次,20 d为1个疗程。对照组化疗同时服用利血生和?肝醇, 利血生片每次20 mg,?肝醇片每次100 mg,均每天3次,20 d为1个疗程。两组患者均完成2个周期化疗。结果:治疗组化疗后骨髓抑制发生率为37.0%,对照组为78.6%,两组比较有显著性差异(P<0.05),粒细胞集落刺激因子用量治疗组低于对照组,两组间有显著性差异(P<0.05),白细胞减少继发感染情况治疗组低于对照组。结论:地榆升白片能有效预防化疗引起的骨髓抑制。 [关键词] 地榆升白片;恶性肿瘤;化疗;骨髓抑制 [中图分类号]R551[文献标识码]B [文章编号]1673-7210(2007)09(c)-049-02 Observation on Diyushengbai tablet to prevent myelosupression of patients treated by chemotherapy LI Hong,YANG Feng (Tumor hospital of Henan Province,Zhengzhou 450003,China) [Abstract] Objective: TO evaluate the effect of the Diyushengbai tablet to prevent myelosuppression of patients with m alignant tumor after chemotherapy. Methods:88 patients with m alignant tumor were enrolled in our study and were randomized into the treatment group, which consisted of 46 cases using Diyushengbai tablets combined with chemotherapy,and the control group in which the patients were treated by leucogen tablets , batilol tablets combined with chemotherapy. The patients in the treatment group were advised to take orally 4 Diyushengbai tablets, three time per day, and those in the control group were given leucogen tablets , batilol tablets ,20 mg and 100 mg respectively,both three time per day. All patients were treated with 2 cycles of regimen that continued 20 days. Results: The incidence of myelosuppressionin the treatment group was significantly lower than that in the control group(37.0% vs 78.6%,P<0.05),and so did the means of used dose of recombinant human granulocyte colony stimulating factor(rhG-CSF) (81.5% vs 53.9%,P<0.05) and the side effects in the treatment group were less and milder than those in the control group. Conclusion: Diyushengbai tablet plays a significant role of enhancing chemotherapy, and alleviated the adverse effects of chemotherapy. [Key words] Diyushengbai tablet;M alignant tumor;Chemotherapy;Myelosuppression 化疗是目前治疗恶性肿瘤的一项重要手段,但

文档评论(0)

docman126 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7042123103000003

1亿VIP精品文档

相关文档